Asia Pacific Non-Invasive Ventilation Masks Market Forecast to 2031 - Regional Analysis

Description

List of Tables

The Asia Pacific non-invasive ventilation masks market was valued at US$ 433.81 million in 2023 and is expected to reach US$ 719.68 million by 2031; it is estimated to register a CAGR of 6.5% from 2023 to 2031.

Increasing Adoption of NIV Masks Drives Asia Pacific Non-Invasive Ventilation Masks Market

Noninvasive ventilation masks are becoming increasingly popular and expanding market opportunities by spurring innovation. Earlier diagnosis and treatment are being made possible by growing awareness campaigns about respiratory disorders such as COPD, sleep apnea, and others. The increased prescription and usage of NIV masks for disease management results from greater awareness among patients and healthcare professionals. Thus, emerging awareness of early diagnosis is likely to drive the adoption of NIV masks and create significant opportunities in the market. Moreover, respiratory illnesses are becoming more common in emerging economies, particularly in Asia Pacific, Latin America, and the Middle East, due to pollution, urbanization, and lifestyle changes. The Noninvasive therapies are becoming widely known in these areas, owing to which the use of NIV masks is likely to continue to propel during the forecast period.

Asia Pacific Non-Invasive Ventilation Masks Market Overview

The Asia Pacific noninvasive ventilation masks market is segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. China held the largest share of the market in the region during the forecast period. The noninvasive ventilation masks market in Asia Pacific is growing due to the surging utilization of NIV masks for the treatment of respiratory diseases such as obstructive sleep apnea, COPD, and neuromuscular disorders prevailing in the region. This growing use of NIV masks is expected to bring opportunities for market players to penetrate into emerging countries in Asia Pacific.

Asia Pacific Non-Invasive Ventilation Masks Market Revenue and Forecast to 2031 (US$ Million)

Asia Pacific Non-Invasive Ventilation Masks Market Segmentation

The Asia Pacific non-invasive ventilation masks market is categorized into product, application, end user, and country.

By product, the Asia Pacific non-invasive ventilation masks market is bifurcated into noninvasive ventilation disposable mask and noninvasive ventilation reusable mask. The noninvasive ventilation disposable mask segment held a larger share of the Asia Pacific non-invasive ventilation masks market share in 2023.

In terms of application, the Asia Pacific non-invasive ventilation masks market is segmented into sleep apnea, chronic obstructive pulmonary disease, pneumonia, and others. The sleep apnea segment held the largest share of the Asia Pacific non-invasive ventilation masks market share in 2023.

Based on end user, the Asia Pacific non-invasive ventilation masks market is segmented into hospitals and clinics, home care, and others. The hospitals and clinics segment held the largest share of the Asia Pacific non-invasive ventilation masks market share in 2023.

Based on country, the Asia Pacific non-invasive ventilation masks market is segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. China segment held the largest share of Asia Pacific non-invasive ventilation masks market in 2023.

Air Liquide Medical Systems; Armstrong Medical Ltd; Besmed Health Business Corp; BMC Medical Co Ltd; DeVilbiss Healthcare LLC; Dimar S.P.A.; Dragerwerk AG & Co KGaA; Fisher & Paykel Healthcare Corp Ltd; Hamilton Medical AG; Hangzhou Formed Medical Devices Co., Ltd; Intersurgical Ltd; Koninklijke Philips NV; Medline Industries LP; ResMed Inc; Sleepnet Corporation; SunMed Group Holdings LLC ( AirLife); and SURU INTERNATIONAL PVT. LTD. are some of the leading companies operating in the Asia Pacific non-invasive ventilation masks market.

Product Code: TIPRE00028762

1. Introduction

1.1 Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Hypothesis formulation:
- 3.2.2 Macroeconomic factor analysis:
- 3.2.3 Developing base number:
- 3.2.4 Data Triangulation:
- 3.2.5 Country-level data:

4. Asia Pacific Non-Invasive Ventilation Masks Market Landscape

4.1 PEST Analysis

5. Asia Pacific Non-Invasive Ventilation Masks Market - Key Market Dynamics

5.1 Asia Pacific Non-Invasive Ventilation Masks Market - Key Market Dynamics
5.2 Market Drivers
- 5.2.1 Increasing Prevalence of Respiratory Diseases
- 5.2.2 Growing Inclination Towards Home Healthcare
5.3 Market Restraints
- 5.3.1 Side Effects Associated with NIV Masks
5.4 Market Opportunities
- 5.4.1 Increasing Adoption of NIV Masks
5.5 Future Trends
- 5.5.1 Rising Technological Advancements
5.6 Impact of Drivers and Restraints:

6. Asia Pacific Non-Invasive Ventilation Masks Market - Analysis

6.1 Asia Pacific Non-Invasive Ventilation Masks Market Revenue (US$ Million), 2021-2031
6.2 Asia Pacific Non-Invasive Ventilation Masks Market Forecast Analysis

7. Asia Pacific Non-Invasive Ventilation Masks Market Analysis - by Product

7.1 Non-Invasive Ventilation Disposable Mask
- 7.1.1 Overview
- 7.1.2 Non-Invasive Ventilation Disposable Mask: Asia Pacific Non-Invasive Ventilation Masks Market - Revenue and Forecast, 2021-2031 (US$ Million)
7.2 Non-Invasive Ventilation Reusable Mask
- 7.2.1 Overview
- 7.2.2 Non-Invasive Ventilation Reusable Mask: Asia Pacific Non-Invasive Ventilation Masks Market - Revenue and Forecast, 2021-2031 (US$ Million)

8. Asia Pacific Non-Invasive Ventilation Masks Market Analysis - by Application

8.1 Sleep Apnea
- 8.1.1 Overview
- 8.1.2 Sleep Apnea: Asia Pacific Non-Invasive Ventilation Masks Market - Revenue and Forecast, 2021-2031 (US$ Million)
8.2 Chronic Obstructive Pulmonary Disease
- 8.2.1 Overview
- 8.2.2 Chronic Obstructive Pulmonary Disease: Asia Pacific Non-Invasive Ventilation Masks Market - Revenue and Forecast, 2021-2031 (US$ Million)
8.3 Pneumonia
- 8.3.1 Overview
- 8.3.2 Pneumonia: Asia Pacific Non-Invasive Ventilation Masks Market - Revenue and Forecast, 2021-2031 (US$ Million)
8.4 Others
- 8.4.1 Overview
- 8.4.2 Others: Asia Pacific Non-Invasive Ventilation Masks Market - Revenue and Forecast, 2021-2031 (US$ Million)

9. Asia Pacific Non-Invasive Ventilation Masks Market Analysis - by End User

9.1 Hospitals and Clinics
- 9.1.1 Overview
- 9.1.2 Hospitals and Clinics: Asia Pacific Non-Invasive Ventilation Masks Market - Revenue and Forecast, 2021-2031 (US$ Million)
9.2 Home Care
- 9.2.1 Overview
- 9.2.2 Home Care: Asia Pacific Non-Invasive Ventilation Masks Market - Revenue and Forecast, 2021-2031 (US$ Million)
9.3 Others
- 9.3.1 Overview
- 9.3.2 Others: Asia Pacific Non-Invasive Ventilation Masks Market - Revenue and Forecast, 2021-2031 (US$ Million)

10. Asia Pacific Non-Invasive Ventilation Masks Market - Country Analysis

10.1 Asia Pacific
- 10.1.1 Asia Pacific Non-Invasive Ventilation Masks Market - Revenue and Forecast Analysis - by Country
  - 10.1.1.1 Asia Pacific Non-Invasive Ventilation Masks Market - Revenue and Forecast Analysis - by Country
  - 10.1.1.2 China: Asia Pacific Non-Invasive Ventilation Masks Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.1.1.2.1 China: Asia Pacific Non-Invasive Ventilation Masks Market Share - by Product
    - 10.1.1.2.2 China: Asia Pacific Non-Invasive Ventilation Masks Market Share - by Application
    - 10.1.1.2.3 China: Asia Pacific Non-Invasive Ventilation Masks Market Share - by End User
  - 10.1.1.3 Japan: Asia Pacific Non-Invasive Ventilation Masks Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.1.1.3.1 Japan: Asia Pacific Non-Invasive Ventilation Masks Market Share - by Product
    - 10.1.1.3.2 Japan: Asia Pacific Non-Invasive Ventilation Masks Market Share - by Application
    - 10.1.1.3.3 Japan: Asia Pacific Non-Invasive Ventilation Masks Market Share - by End User
  - 10.1.1.4 India: Asia Pacific Non-Invasive Ventilation Masks Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.1.1.4.1 India: Asia Pacific Non-Invasive Ventilation Masks Market Share - by Product
    - 10.1.1.4.2 India: Asia Pacific Non-Invasive Ventilation Masks Market Share - by Application
    - 10.1.1.4.3 India: Asia Pacific Non-Invasive Ventilation Masks Market Share - by End User
  - 10.1.1.5 Australia: Asia Pacific Non-Invasive Ventilation Masks Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.1.1.5.1 Australia: Asia Pacific Non-Invasive Ventilation Masks Market Share - by Product
    - 10.1.1.5.2 Australia: Asia Pacific Non-Invasive Ventilation Masks Market Share - by Application
    - 10.1.1.5.3 Australia: Asia Pacific Non-Invasive Ventilation Masks Market Share - by End User
  - 10.1.1.6 South Korea: Asia Pacific Non-Invasive Ventilation Masks Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.1.1.6.1 South Korea: Asia Pacific Non-Invasive Ventilation Masks Market Share - by Product
    - 10.1.1.6.2 South Korea: Asia Pacific Non-Invasive Ventilation Masks Market Share - by Application
    - 10.1.1.6.3 South Korea: Asia Pacific Non-Invasive Ventilation Masks Market Share - by End User
  - 10.1.1.7 Rest of APAC: Asia Pacific Non-Invasive Ventilation Masks Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.1.1.7.1 Rest of APAC: Asia Pacific Non-Invasive Ventilation Masks Market Share - by Product
    - 10.1.1.7.2 Rest of APAC: Asia Pacific Non-Invasive Ventilation Masks Market Share - by Application
    - 10.1.1.7.3 Rest of APAC: Asia Pacific Non-Invasive Ventilation Masks Market Share - by End User

11. Industry Landscape

11.1 Overview
11.2 Growth Strategies in Noninvasive Ventilation Mask Market
11.3 Organic Growth Strategies
- 11.3.1 Overview
11.4 Inorganic Growth Strategies
- 11.4.1 Overview

12. Company Profiles

12.1 Hamilton Medical AG
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 ResMed Inc
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 Fisher & Paykel Healthcare Corp Ltd
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 Air Liquide Medical Systems
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 Dragerwerk AG & Co KGaA
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 Intersurgical Ltd
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
12.7 BMC Medical Co Ltd
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
12.8 DeVilbiss Healthcare LLC
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments
12.9 Armstrong Medical Ltd
- 12.9.1 Key Facts
- 12.9.2 Business Description
- 12.9.3 Products and Services
- 12.9.4 Financial Overview
- 12.9.5 SWOT Analysis
- 12.9.6 Key Developments
12.10 Koninklijke Philips NV
- 12.10.1 Key Facts
- 12.10.2 Business Description
- 12.10.3 Products and Services
- 12.10.4 Financial Overview
- 12.10.5 SWOT Analysis
- 12.10.6 Key Developments
12.11 Besmed Health Business Corp
- 12.11.1 Key Facts
- 12.11.2 Business Description
- 12.11.3 Products and Services
- 12.11.4 Financial Overview
- 12.11.5 SWOT Analysis
- 12.11.6 Key Developments
12.12 Sleepnet Corporation.
- 12.12.1 Key Facts
- 12.12.2 Business Description
- 12.12.3 Products and Services
- 12.12.4 Financial Overview
- 12.12.5 SWOT Analysis
- 12.12.6 Key Developments
12.13 SunMed Group Holdings LLC ( AirLife)
- 12.13.1 Key Facts
- 12.13.2 Business Description
- 12.13.3 Products and Services
- 12.13.4 Financial Overview
- 12.13.5 SWOT Analysis
- 12.13.6 Key Developments
12.14 Dimar S.P.A.
- 12.14.1 Key Facts
- 12.14.2 Business Description
- 12.14.3 Products and Services
- 12.14.4 Financial Overview
- 12.14.5 SWOT Analysis
- 12.14.6 Key Developments
12.15 Hangzhou Formed Medical Devices Co., Ltd
- 12.15.1 Key Facts
- 12.15.2 Business Description
- 12.15.3 Products and Services
- 12.15.4 Financial Overview
- 12.15.5 SWOT Analysis
- 12.15.6 Key Developments
12.16 SURU INTERNATIONAL PVT. LTD.
- 12.16.1 Key Facts
- 12.16.2 Business Description
- 12.16.3 Products and Services
- 12.16.4 Financial Overview
- 12.16.5 SWOT Analysis
- 12.16.6 Key Developments
12.17 Medline Industries LP
- 12.17.1 Key Facts
- 12.17.2 Business Description
- 12.17.3 Products and Services
- 12.17.4 Financial Overview
- 12.17.5 SWOT Analysis
- 12.17.6 Key Developments

13. Appendix

13.1 About Us
13.2 List of Abbreviations